TCIM
AMRI

TIAA CREF Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

TIAA CREF Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-69,609
Closed -$1.51M – 3127
2017
Q2 		$1.51M Sell
69,609
-140
-0.2% -$2.54K ﹤0.01% 2348
2017
Q1 		$979K Sell
69,749
-3,134
-4% -$51.3K ﹤0.01% 2517
2016
Q4 		$1.37M Sell
72,883
-7,697
-10% -$131K ﹤0.01% 2381
2016
Q3 		$1.33K Sell
80,580
-2,084
-3% -$30.9K ﹤0.01% 2391
2016
Q2 		$1.11M Buy
82,664
+1,352
+2% +$19.7K ﹤0.01% 2452
2016
Q1 		$1.24M Hold
81,312
– – ﹤0.01% 2353
2015
Q4 		$1.61M Sell
81,312
-2,871
-3% -$54.6K ﹤0.01% 2288
2015
Q3 		$1.47M Sell
84,183
-2,535
-3% -$51.6K ﹤0.01% 2332
2015
Q2 		$1.75M Sell
86,718
-12,598
-13% -$243K ﹤0.01% 2383
2015
Q1 		$1.75M Sell
99,316
-2,655
-3% -$45.2K ﹤0.01% 2301
2014
Q4 		$1.66M Sell
101,971
-3,036
-3% -$55.7K ﹤0.01% 2362
2014
Q3 		$2.32M Sell
105,007
-1,282
-1% -$26.3K ﹤0.01% 2127
2014
Q2 		$2.14M Buy
106,289
+5,176
+5% +$87.7K ﹤0.01% 2267
2014
Q1 		$1.88M Sell
101,113
-2,340
-2% -$32.2K ﹤0.01% 2272
2013
Q4 		$1.04M Hold
103,453
– – ﹤0.01% 2653
2013
Q3 		$1.33M Sell
103,453
-5,147
-5% -$63.3K ﹤0.01% 2445
2013
Q2 		$1.29M Buy
+108,600
New +$1.18M ﹤0.01% 2419

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

TIAA CREF Investment Management's AMRI Position: Q3 2017 in Review

TIAA CREF Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 69,609 shares — an estimated $1.51M sold.

TIAA CREF Investment Management first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $2.32M in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • TIAA CREF Investment Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 69,609 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.51M.
  • TIAA CREF Investment Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • TIAA CREF Investment Management's Albany Molecular Research Inc position peaked at $2.32M in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on TIAA CREF Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.